Arcutis Biotherapeutics Inc (ARQT)

Jun 15, 2026

[144] Arcutis Biotherapeutics, Inc. SEC Filing - Stock Titan

Jun 15, 2026

Jun 13, 2026

Arcutis Biotherapeutics (ARQT) Slips Slightly as Stock Holds Above Key SupportZero Gamma Level - newsline.com

Jun 13, 2026

Jun 12, 2026

Arcutis (ARQT) director amends filing to correct indirect share count - Stock Titan

Jun 12, 2026

Jun 11, 2026

Arcutis Biotherapeutics touts ZORYVE growth, FDA catalysts and cash-flow positive status - MSN

Jun 11, 2026

Jun 11, 2026

Is Arcutis (ARQT) Using Genital Psoriasis Education to Quietly Reshape Its Dermatology Strategy? - Yahoo Finance

Jun 11, 2026

Jun 11, 2026

Arcutis Biotherapeutics, Inc. (ARQT) reports Q1 loss, beats revenue estimates - MSN

Jun 11, 2026

Jun 11, 2026

GW&K Investment Management LLC Sells 163,461 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat

Jun 11, 2026

Jun 10, 2026

Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat

Jun 10, 2026

Jun 09, 2026

Arcutis Biotherapeutics Touts ZORYVE Growth, FDA Catalysts and Cash-Flow Positive Status - sharewise.com

Jun 09, 2026

Jun 09, 2026

Arcutis (ARQT) director receives RSU grant and 16,667-share stock option - Stock Titan

Jun 09, 2026

Jun 09, 2026

[Form 4] Arcutis Biotherapeutics, Inc. Insider Trading Activity - Stock Titan

Jun 09, 2026

Jun 09, 2026

Arcutis Stockholders Approve Proposals at 2026 Meeting - TipRanks

Jun 09, 2026

Jun 09, 2026

Arcutis Biotherapeutics (ARQT) 2026 meeting OKs directors, auditor and executive pay - Stock Titan

Jun 09, 2026

Jun 09, 2026

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors - GlobeNewswire Inc.

Jun 09, 2026

Jun 08, 2026

Geode Capital Management LLC Has $79.97 Million Stock Holdings in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat

Jun 08, 2026

Jun 05, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 05, 2026

Jun 05, 2026

Six new Arcutis hires receive 44,000 restricted stock units - Stock Titan

Jun 05, 2026

Jun 05, 2026

Earnings call transcript: Arcutis Biotherapeutics Q1 2026 sees revenue beat, EPS miss - Investing.com

Jun 05, 2026

Jun 05, 2026

Arcutis Biotherapeutics EVP Masaru Matsuda sells $192k in stock - Investing.com

Jun 05, 2026

Jun 05, 2026

ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Chart - ChartMill

Jun 05, 2026

Jun 03, 2026

New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology - StreetInsider

Jun 03, 2026

Jun 03, 2026

New Expert Consensus Provides Age-Specific Guidance for - GlobeNewswire

Jun 03, 2026

Jun 03, 2026

Mizuho Securities Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $35 - Moomoo

Jun 03, 2026

May 31, 2026

Hillsdale Investment Management Inc. Invests $5.21 Million in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat

May 31, 2026

May 30, 2026

ARQT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

May 30, 2026

May 29, 2026

ARQT News | ARCUTIS BIOTHERAPEUTICS INC (NASDAQ:ARQT) - ChartMill

May 29, 2026

May 28, 2026

(ARQT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 28, 2026

May 27, 2026

A Quick Look at Today's Ratings for Arcutis Biotherapeutics(ARQT.US), With a Forecast Between $34 to $37 - Moomoo

May 27, 2026

May 26, 2026

Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference - The Globe and Mail

May 26, 2026

May 26, 2026

Insiders At Arcutis Biotherapeutics Sold US$4.4m In Stock, Alluding To Potential Weakness - Moomoo

May 26, 2026

May 17, 2026

Arcutis Biotherapeutics (ARQT) Price Target Increased by 32.62% to 31.62 - MSN

May 17, 2026

May 17, 2026

How (ARQT) Movements Inform Risk Allocation Models - Stock Traders Daily

May 17, 2026

May 15, 2026

Number of shareholders of Arcutis Biotherapeutics, Inc. – NASDAQ:ARQT - TradingView

May 15, 2026

May 15, 2026

Arcutis Biotherapeutics: The Dermatology Platform Is Starting To Compound (NASDAQ:ARQT) - Seeking Alpha

May 15, 2026

May 14, 2026

Arcutis Biotherapeutics, Inc.Common stock (NQ: ARQT - FinancialContent

May 14, 2026

May 14, 2026

Arcutis Biotherapeutics SVP CFO Latha Vairavan sells $9,156 in stock. By Investing.com - Investing.com UK

May 14, 2026

May 13, 2026

Arcutis Biotherapeutics SVP CFO Latha Vairavan sells $9,156 in stock. - Investing.com UK

May 13, 2026

May 13, 2026

Arcutis EVP, CMO Burnett sells $4,673 in common stock - Investing.com UK

May 13, 2026

May 13, 2026

Arcutis EVP, CMO Burnett sells $4,673 in common stock By Investing.com - Investing.com South Africa

May 13, 2026

May 13, 2026

Arcutis (ARQT) CFO tax-related sale of 435 shares after RSU vesting - Stock Titan

May 13, 2026

May 13, 2026

Arcutis Biotherapeutics (ARQT) officer sells 222 shares to cover RSU tax - Stock Titan

May 13, 2026

May 12, 2026

Arcutis Q1 2026 slides: revenue surges 65% amid expansion push By Investing.com - Investing.com Nigeria

May 12, 2026

May 12, 2026

Arcutis Q1 2026 slides: revenue surges 65% amid expansion push - Investing.com

May 12, 2026

May 12, 2026

Earnings call transcript: Arcutis Biotherapeutics Q1 2026 misses EPS expectations By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

Earnings call transcript: Arcutis Biotherapeutics Q1 2026 misses EPS expectations - Investing.com Nigeria

May 12, 2026

May 12, 2026

State Street (NYSE: STT) holds 6.30M shares of Arcutis (5.1%) - Stock Titan

May 12, 2026